The inhibitory effect of citromycin on the migration of human ovarian cancer cells was comparable to that of galnuisertib, a potent inhibitor of TGFβ signaling, which is well known to activate cancer cell EMT, migration, and invasion (Figure S4). The gene discussed is TGFB1; the disease is ovarian carcinoma.